← Leaderboards
Yuhao Shi
Roswell Park Cancer Institute Corp
$62,560
Attributed
$62,560
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $31.5K · FY2020–21$50K$37.5K$25K$12.5K$0
'20
'21
Funding mix
By agency
NIH$62,560 · 1
By mechanism
F30$62,560 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Scott I. Abrams$11,133,748
- Hyung L Kim$6,429,617
- Soldano Ferrone$11,688,743
- Walter J Storkus$19,974,413
- Kirsten B Moysich$9,727,320
Others in their field
Other Emerging Leaders on “Angiogenesis Pathway”
- Bradley David Gelfand · University Of Virginia$5,118,674
- Patrice Mimche · University Of Utah$4,267,251
- Sana D Karam · University Of Colorado Denver$4,039,397
- Brandie Depaoli Taylor · Temple Univ Of The Commonwealth$3,796,278
- Jenny Huanjiao Zhou · Yale University$3,768,750
- Alex K. Wong · University Of Southern California$3,193,446
Research focus
Angiogenesis PathwayAnti-CancerAntineoplastic AgentsAnti-Pd-L1Anti-Pd-L1 TherapyBindingCancer TypeCcl2 GeneCell GrowthCell PhysiologyCellsChronicClinical TrialsCytokineCytoplasmic TailDesensitizationEfficacy TestingExperimental StudyExposure ToExtracellularFailureIl6 GeneImmuneAftercare